Incluye referencias bibliográficas e índice

Acknowledgment; Contents; Contributors; Part I: Pathophysiology and Diagnosis of CME; Chapter 1: Introduction; Chapter 2: Mechanisms of€Macular Edema; Introduction; Mechanisms Leading to€ME; Mechanisms Leading to€Increased Retinal Fluid Entry or "Vasogenic" Mechanisms; Starling Equation; Rupture of€Retinal Barriers; Vascular Abnormalities Associated with€Enhanced Permeability; RPE Dysfunction; Mechanisms Leading to€Reduced Retinal Fluid Exit or "Cytotoxic" Mechanisms: Retinal Müller Glia Dysfunction; Mechanical Tractions; Causes of€Macular Edema; Vasogenic Macular Edema.

Anti-vascular Endothelial Growth Factor Medications Intravitreal Methotrexate; Subcutaneous Interferon Alpha; Antitumor Necrosis Factor Alpha Medications; Choosing the€Right Treatment; References; Chapter 5: Medical Management of€CME Associated with€Diabetes; Introduction; Pathophysiology of€DME; Medical Management of€DME; Systemic Control [10, 11]; Glycemic Control; Blood Pressure Control; Renin-Angiotensin System Inhibition; Lipid-Lowering Agents; Topical Therapy; Nonsteroidal Anti-inflammatory Drugs (NSAIDS); Steroids; Other Topical Agents; Intraocular Therapy; Steroids.

Anti-VEGF Summary; References; Chapter 6: Management of€Macular Edema in€Vitreo-Maculopathies; Introduction; Vitreous Biochemistry and€Structure; Aging and€PVD; Anomalous PVD; Primary Vitreo-Maculopathies (APVD Is the€Primary Cause); Vitreo-Macular Traction (VMT); Macular Holes (MH); Macular Pucker (MP); Comorbid Vitreo-Maculopathies (Vitreous Contributes); Vitreous in€Exudative AMD; Vitreous in€Diabetic Macular Edema (DME); Vitreous in€Macular Edema due€to€Retinal Vein Occlusion (RVO); Therapy; Surgical; Chromodissection.

CME Associated with€Vitreoretinal Interface Abnormalities CME Associated with€Uveitis; Role of€Fundus Autofluorescence Imaging in€CME; En Face C-Scan Imaging in€CME; Further Advances in€Imaging CME; Conclusion; References; Part II: Medical Management of CME; Chapter 4: Medical Management of€CME Associated with€Uveitis; Introduction; Nonsteroidal Anti-inflammatory Medications; Corticosteroids; Topical Corticosteroids; Systemic Corticosteroids; Periocular Corticosteroids; Intravitreal Corticosteroids; Intravitreal Corticosteroid Depot Preparations; Ozurdex; Retisert.

Retinal Vein Occlusion Diabetic Macular Edema (DME); Hypertensive Retinopathy; Inflammatory Macular Edema; Macular Edema and€Choroidal Neovascularization; Cytotoxic Macular Edema; Chemotherapy-Induced Macular Edema; Retinal/Choroidal Ischemia and€Macular Edema; Conclusion; References; Chapter 3: Diagnosis of€Cystoid Macular Edema: Imaging; Introduction; CME Associated with€Diabetes: Diabetic Macular Edema; Imaging the€Choroid in€DME; Fluorescein Angiography in€DME; Pseudophakic Cystoid Macular Edema; CME Associated with€Retinal Vascular Occlusions.

Written for comprehensive ophthalmologists and vitreoretinal surgeons, this book discusses state-of-the-art medical and surgical management of cystoid macular edema (CME) and explains the current understanding of the pathophysiology of the condition and methods of diagnosis. The management approach is clearly detailed for each potential presentation, including CME occurring in association with uveitis, diabetes mellitus, vitreoretinal interface changes, retinal vascular occlusions, and lens-induced pathology. The guidance takes full account of the continued expansion in medical treatment options due to the development of new drugs and the increased availability of minimally invasive surgical procedures. Additionally, since therapeutic approaches to CME depend on a clear understanding of pathophysiologic mechanisms and the structural changes in the vitreous and neurosensory retina revealed by imaging studies, these aspects are carefully considered as well.